Previous studies have reached the conclusion that GnRH-a (LA) administration in women with endometriosis or uterine fibroids downregulated VEGF expression and affected the vascular pattern via decrease of microvessel density in the endometria studied [31–33]. This evidence concerns the gene VEGFA and endometriosis.